EIDO Performance — iShares MSCI Indonesia ETF
Data updated: 2026-07-27
EIDO returned −32.03% year to date and −30.51% over one year to May 2026. Annualised returns are −15.43% over 3 years and −7.10% over 5 years. The fund trailed its Indonesia Equity category average: $100 invested three years ago grew to $60, against $63 for the category, and to $69 over one year, against $72. Volatility over the past three years was 20.01% a year. In the 12 months to May 2026 the fund took in a net $95.2M, and assets reached $288.61M.
EIDO Growth of $100
What $100 invested in iShares MSCI Indonesia ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Indonesia Equity category average over the same months.
| Period | EIDO | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $69 | $72 |
| 3 years (Jun 2023 – May 2026) | $60 | $63 |
| 5 years (Jun 2021 – May 2026) | $69 | $68 |
| Since data start (Sep 2019 – May 2026) | $60 | $59 |
EIDO Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −32.03% |
| 1 year | −30.51% |
| 3 years (annualised) | −15.43% |
| 5 years (annualised) | −7.10% |
EIDO Annual Returns
Calendar-year total returns of iShares MSCI Indonesia ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | −32.03% |
| 2025 | +2.98% |
| 2024 | −11.40% |
| 2023 | +2.09% |
| 2022 | −0.42% |
| 2021 | +0.87% |
| 2020 | −8.10% |
| 2019 (Sep–Dec) | +1.93% |
EIDO Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −3.0% | −0.5% | −13.6% | −5.1% | −14.1% | — | — | — | — | — | — | — |
| 2025 | −1.7% | −14.1% | +3.5% | +5.2% | +9.5% | −4.7% | −0.8% | +1.5% | −0.7% | +4.2% | +1.7% | +1.3% |
| 2024 | −2.2% | +2.9% | +1.0% | −7.9% | −5.1% | +1.3% | +4.2% | +9.0% | +2.3% | −4.4% | −7.0% | −4.6% |
| 2023 | +4.0% | −1.8% | +2.3% | +5.0% | −4.7% | +0.6% | +1.0% | −1.3% | −3.0% | −8.2% | +5.4% | +3.5% |
| 2022 | +0.1% | +4.8% | +2.0% | +2.8% | −2.3% | −8.5% | +3.1% | +3.9% | −2.1% | +1.1% | +0.5% | −5.0% |
| 2021 | −2.6% | +2.8% | −6.8% | +0.7% | −2.2% | −4.0% | −1.8% | +7.0% | +2.9% | +9.0% | −3.3% | +0.4% |
| 2020 | −4.0% | −12.8% | −30.9% | +14.1% | +2.6% | +7.6% | +3.2% | +3.0% | −12.7% | +5.2% | +20.5% | +7.2% |
| 2019 | — | — | — | — | — | — | — | — | −2.7% | +2.5% | −4.4% | +6.8% |
EIDO Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 20.01%
- 3-year Sharpe ratio: -1.00 (vs 4.5% risk-free rate)
- Best month: +9.53% (May 2025)
- Worst month: −14.15% (May 2026)
EIDO Fund Flows
Monthly money in and out of iShares MSCI Indonesia ETF, from SEC Form N-PORT.
- 12-month net flow: $95.2M
- 12-month gross sales (incl. reinvestments): $247.0M
- Sales ÷ redemptions: 1.63×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $51.2M | $0 | $51.2M |
| Apr 2026 | $27.2M | $0 | $27.2M |
| Mar 2026 | $2.4M | $39K | $2.4M |
| Feb 2026 | $0 | $23.9M | −$23.9M |
| Jan 2026 | $4.8M | $19.6M | −$14.9M |
| Dec 2025 | $43.9M | $0 | $43.9M |
| Nov 2025 | $0 | $4.6M | −$4.6M |
| Oct 2025 | $0 | $0 | $0 |
| Sep 2025 | $5.3M | $27.0M | −$21.7M |
| Aug 2025 | $99.7M | $10.5M | $89.2M |
| Jul 2025 | $10.6M | $9.7M | $955K |
| Jun 2025 | $1.8M | $56.3M | −$54.5M |
EIDO Assets Under Management
Net assets of iShares MSCI Indonesia ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $288.61M |
| 2026-02-28 | $310.15M |
| 2025-11-30 | $317.42M |
| 2025-08-31 | $328.19M |
| 2025-05-31 | $319.19M |
| 2025-02-28 | $244.50M |
| 2024-11-30 | $297.40M |
| 2024-08-31 | $344.89M |
| 2024-05-31 | $385.49M |
| 2024-02-29 | $501.75M |
| 2023-11-30 | $398.72M |
| 2023-08-31 | $498.50M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.